Sveriges mest populära poddar
The Curbsiders Internal Medicine Podcast

REBOOT #146 Pain Meds in CKD

1 tim 7 min21 mars 2022
We tackle the complexities of pain management in patients with chronic kidney disease in this reboot from @NephMadness 2019 that, on a scale of 1-10, will leave you feeling very relieved in addressing pain. Topics: Opioids, gabapentinoids, NSAIDS, pain ladders, why tramadol is tramadont, and more!
Episodes | Subscribe | Spotify | Swag! | Top Picks | Mailing List | [email protected] | Free CME!
Credits
  • Written and produced by: Justin Berk MD
  • NephMadness Pain Region: Samantha Gelfand MD
  • NephMadness Pun Contest produced by: Hannah R Abrams
  • Cover art by: Kate Grant MBChB, Dip GUMed
  • Hosts: Matthew Watto MD, Paul Williams MD, Stuart Brigham MD
  • Edited by: Matthew Watto MD (audio), Emi Okamoto MD (show notes)
  • Guests:  Samantha Gelfand MD, Matthew Sparks MD, David Juurlink MD

Show Segments
  • Kidney Pun
  • Disclaimer, intro and guest bios
  • Guest one-liners
  • Clinical Case and Pain Management Disclaimer
  • Modalities for pain meds in ckd
  • Opioids for pain and their metabolites
  • Dave Juurlink reframes the question, “what is our real goal with pain management?”
  • Matt Sparks reiterates the dangers of morphine and codeine in patients with advanced CKD
  • Communicating meds that are contraindicated or relatively contraindicated in CKD
  • Buprenorphine
  • What about the WHO Pain Ladder for CKD?
  • Should we use more cannabinoids? Ketamine?
  • Dave Juurlink rants on Tramadol
  • NSAIDS and CKD
  • Gabapentinoids (gabapentin and pregabalin) for neuropathic pain and driving?!
  • Estimating eGFR in CKD and AKI. Which equation is best?
  • How would each of our experts treat this patient with CKD and knee pain
  • Outro


Sponsors: 

Fler avsnitt av The Curbsiders Internal Medicine Podcast

Visa alla avsnitt av The Curbsiders Internal Medicine Podcast

The Curbsiders Internal Medicine Podcast med The Curbsiders Internal Medicine Podcast finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.